REFERENCES

(1)   Van Os EC, Kamath PS, Gostout CJ, Heit JA. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc 1999; 50:536-43.

(2)   Buckley A, Petrunia D. Practice guidelines for liver biopsy. Canadian Association of Gastroenterology. Can J Gastroenterol 2000; 14:481-2.

(3)   Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978; 74:103-6.

(4)   Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: how safe is it? Ann Intern Med 1993; 118:150-3.

(5)   Sue M, Caldwell SH, Dickson RC, Macalindong C, Rourk RM, Charles C et al. Variation between centers in technique and guidelines for liver biopsy. Liver 1996; 16:267-70.

(6)   Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993; 118:96-8.

(7)   Vivas S, Palacio MA, Rodriguez M, Lomo J, Cadenas F, Giganto F et al. Ambulatory liver biopsy: complications and evolution in 264 cases. Rev Esp Enferm Dig 1998; 90:175-82.

(8)   McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99:1396-400.

(9)   Craxi A, Camma C, Giunta M. Clinical aspects of bleeding complications in cirrhotic patients. Blood Coagul Fibrinolysis 2000; 11 Suppl 1:S75-9.

(10)   Ahmed MM, Mutimer DJ, Elias E, Linin J, Garrido M, Hubscher S et al. A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. Br J Haematol 1996; 95:383-8.

(11)   Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26:388-93.

(12)   Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36:437-41.

(13)   Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 1994; 71:727-30.

(14)   Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24:1392-4.

(15)   Colapinto RF. Transjugular biopsy of the liver. Clin Gastroenterol 1985; 14:451-67.

(16)   Caturelli E, Squillante MM, Andriulli A, Siena DA, Cellerino C, De Luca F et al. Fine-needle liver biopsy in patients with severely impaired coagulation. Liver 1993; 13:270-3.

(17)   Buscarini L, Fornari F, Bolondi L, Colombo P, Livraghi T, Magnolfi F et al. Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. J Hepatol 1990; 11:344-8.

(18)   Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2:165-73.

(19)   Lachaux A, Le Gall C, Chambon M, Regnier F, Loras-Duclaux I, Bouvier R et al. Complications of percutaneous liver biopsy in infants and children. Eur J Pediatr 1995; 154:621-3.

(20)   Chuah SY, Moody GA, Wicks AC, Mayberry JF. A nationwide survey of liver biopsy--is there a need to increase resources, manpower and training? Hepatogastroenterology 1994; 41:4-8.

(21)   Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:495-500.

(22)   Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32:477-81.

(23)   Denninger MH. Haemostasis in liver disease. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J, editors. Oxford textbook of Clinical Hepatology. Oxford: Oxford University Press, 1999: 1795-815.

(24)   Hunt CM, Carson KL, Ortel TL. Combined factor IX and XI deficiency discovered at liver biopsy. Dig Dis Sci 1997; 42:1731-3.

(25)   Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993; 38:1480-4.

(26)   Cadranel JF, Rufat P, Degos F. Pratiques de la ponction-biopsie hépatique transpariétale en France. Résultats d'une étude nationale rétrospective. Gastroenterol Clin Biol 2001; 25:77-80.

(27)   Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982; 83:338-40.

(28)   Dillon JF, Simpson KJ, Hayes PC. Liver biopsy bleeding time: an unpredictable event. J Gastroenterol Hepatol 1994; 9:269-71.

(29)   Bonnard P, Vitte RL, Barbare JC, Denis J, Stepani P, Di M, V et al. Is bleeding time measurement useful for choosing the liver biopsy route? The results of a pragmatic, prospective multicentric study in 219 patients. J Clin Gastroenterol 1999; 29:347-9.

(30)   Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol 1982; 4:451-3.

(31)   Degos F, Benhamou JP. Liver biopsy. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J, editors. Clinical Hepatology. Oxford: Oxford University Press, 1999: 541-5.

(32)   Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost 1999; 81:378-81.

(33)   Blake JC, Sprengers D, Grech P, McCormick PA, McIntyre N, Burroughs AK. Bleeding time in patients with hepatic cirrhosis. BMJ 1990; 301:12-5.

(34)   Mikhailidis DP, Jenkins WJ, Barradas MA, Jeremy JY, Dandona P. Platelet function defects in chronic alcoholism. Br Med J (Clin Res Ed) 1986; 293:715-8.

(35)   McAfee JH, Keeffe EB, Lee RG, Rosch J. Transjugular liver biopsy. Hepatology 1992; 15:726-32.

(36)   Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138:152-63.

(37)   Huber K, Kirchheimer JC, Korninger C, Binder BR. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. Thromb Res 1991; 62:491-500.

(38)   Forestier F, Boisson J, Samama M. Contre-indications de la ponction biopsie hépatique. Sem Hop 1975; -51:2815-7.

(39)   Scott DA, Netchvolodoff CV, Bacon BR. Delayed subcapsular hematoma after percutaneous liver biopsy as a manifestation of warfarin toxicity. Am J Gastroenterol 1991; 86:503-5.

(40)   anonymous. Guidelines on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 1998; 48:672-675.

(41)   McMahon C, Pilkington R, Shea EO, Kelleher D, Smith OP. Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders. Br J Haematol 2000; 109:354-9.

(42)   Fried MW. Management of hepatitis C in the hemophilia patient. Am J Med 1999; 107:85S-89S.

(43)   Giangrande PL. Hepatitis in haemophilia. Br J Haematol 1998; 103:1-9.

(44)   Wong VS, Baglin T, Beacham E, Wight DD, Petrik J, Alexander GJ. The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol 1997; 97:343-7.

(45)   Hanley JP, Jarvis LM, Andrews J, Dennis R, Lee R, Simmonds P et al. Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods. Br J Haematol 1996; 94:159-65.

(46)   Fukuda Y, Nakano I, Katano Y, Toyoda H, Imoto M, Takamatsu J et al. Assessment and treatment of liver disease in Japanese haemophilia patients. Haemophilia 1998; 4:595-600.

(47)   Cohen LJ, McWilliams NB, Neuberg R, Zinkham W, Bauer K, Gribble TJ et al. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports. Am J Hematol 1995; 50:269-76.

(48)   Aledort LM, Levine PH, Hilgartner M, Blatt P, Spero JA, Goldberg JD et al. A study of liver biopsies and liver disease among hemophiliacs. Blood 1985; 66:367-72.

(49)   Beurton I, Bertrand MA, Bresson-Hadni S, Parquet-Gernez A, Goudemand J, Paris JC et al. Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patients. Eur J Gastroenterol Hepatol 2001; 13:859-64.

(50)   Morris JS, Gallo GA, Scheuer PJ, Sherlock S. Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology 1975; 68(4 Pt 1):750-4.

(51)   Le Frock JL, Ellis CA, Turchik JB, Zawacki JK, Weinstein L. Transient bacteremia associated with percutaneous liver biopsy. J Infect Dis 1975; 131 Suppl:S104-7.

(52)   Little AF, Ferris JV, Dodd GD, III, Baron RL. Image-guided percutaneous hepatic biopsy: effect of ascites on the complication rate. Radiology 1996; 199:79-83.

(53)   Murphy FB, Barefield KP, Steinberg HV, Bernardino ME. CT- or sonography-guided biopsy of the liver in the presence of ascites: frequency of complications. AJR Am J Roentgenol 1988; 151:485-6.

(54)   Filice C, Pirola F, Brunetti E, Dughetti S, Strosselli M, Foglieni CS. A new therapeutic approach for hydatid liver cysts. Aspiration and alcohol injection under sonographic guidance. Gastroenterology 1990; 98:1366-8.

(55)   Khuroo MS, Wani NA, Javid G, Khan BA, Yattoo GN, Shah AH et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997; 337:881-7.

(56)   Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 1997; 25:118-21.

(57)   Dao T, Davy A, Verwaerde JC, Galateau F, Valla A. Amylose hépatique. Gastroenterol Clin Biol 1990; 14:534-43.

(58)   Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 1988; 85:73-80.

(59)   Zambon G, Prandoni P, Maragno I, Breda A, Franch R, Scatigna M. [Hepatic injury in mitral valvular cardiopathy. Clinical and diagnostic aspects]. Minerva Med 1987; 78:79-87.

(60)   Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343:931-6.

(61)   Weik C, Greiner L. The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). Scand J Gastroenterol 1999; 34:1241-6.

(62)   Lindner H. [Hazards of percutaneous liver biopsy]. Med Klin 1971; 66:924-9.

(63)   Remuzzi G, Rossi C. Effect of renal failure on hemostasis. In: Brenner BM, editor. The kidney. Philadelphia: Saunders, 1996.

(64)   Stiles KP, Yuan CM, Chung EM, Lyon RD, Lane JD, Abbott KC. Renal biopsy in high-risk patients with medical diseases of the kidney. Am J Kidney Dis 2000; 36:419-33.

(65)   Eberst ME, Berkowitz LR. Hemostasis in renal disease: pathophysiology and management. Am J Med 1994; 96:168-79.

(66)   Ozdogan M, Ozgur O, Boyacioglu S, Coskun M, Kart H, Ozdal S et al. Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron 1996; 74:442-3.

(67)   Falck-Ytter Y, McCullough AJ. The risks of percutaneous liver biopsy. Hepatology 2001; 33:764.

(68)   Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996; 23:1079-83.

(69)   Minuk GY, Sutherland LR, Wiseman DA, MacDonald FR, Ding DL. Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. Gastroenterology 1987; 92:290-3.

(70)   Lichtenstein DR, Kim D, Chopra S. Delayed massive hemobilia following percutaneous liver biopsy: treatment by embolotherapy. Am J Gastroenterol 1992; 87:1833-8.

(71)   Cacho G, Abreu L, Calleja JL, Prados E, Albillos A, Chantar C et al. Arterioportal fistula and hemobilia with associated acute cholecystitis: a complication of percutaneous liver biopsy. Hepatogastroenterology 1996; 43:1020-3.

(72)   Larson AM, Chan GC, Wartelle CF, McVicar JP, Carithers RL, Jr., Hamill GM et al. Infection complicating percutaneous liver biopsy in liver transplant recipients. Hepatology 1997; 26:1406-9.

(73)   Riley TR, III. How often does ultrasound marking change the liver biopsy site? Am J Gastroenterol 1999; 94:3320-2.

(74)   Okuda K, Musha H, Nakajima Y, Takayasu K, Suzuki Y, Morita M et al. Frequency of intrahepatic arteriovenous fistula as a sequela to percutaneous needle puncture of the liver. Gastroenterology 1978; 74:1204-7.

(75)   Sato M, Ishida H, Konno K, Komatsuda T, Hamashima Y, Naganuma H et al. Longstanding arterioportal fistula after laparoscopic liver biopsy. Abdom Imaging 1999; 24:383-5.

(76)   Lim JH, Lee SJ, Lee WJ, Lim HK, Choo SW, Choo IW. Iodized oil retention due to postbiopsy arterioportal shunt: a false positive lesion in the investigation of hepatocellular carcinoma. Abdom Imaging 1999; 24:165-70.

(77)   Pisani RJ, Zeller FA. Bilious pleural effusion following liver biopsy. Chest 1990; 98:1535-7.

(78)   Verhille MS, Munoz SJ. Acute biliary-vascular fistula following needle aspiration of the liver. Gastroenterology 1991; 101:1731-3.

(79)   Papini E, Pacella CM, Rossi Z, Bizzarri G, Fabbrini R, Nardi F et al. A randomized trial of ultrasound-guided anterior subcostal liver biopsy versus the conventional Menghini technique. J Hepatol 1991; 13:291-7.

(80)   Joly JP, Khouani S, Decrombecque C, Razafimahaleo A, Sevestre H, Capron JP. La ponction-biopsie hépatique échoguidée pourrait remplacer la ponction-biopsie à l'aveugle dans les hépatopathies diffuses. Une étude rétrospective chez 1293 patients. Gastroenterol Clin Biol 1995; 19:703-6.

(81)   Caturelli E, Giacobbe A, Facciorusso D, Bisceglia M, Villani MR, Siena DA et al. Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol 1996; 91:1318-21.

(82)   Farrell RJ, Smiddy PF, Pilkington RM, Tobin AA, Mooney EE, Temperley IJ et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol 1999; 30:580-7.

(83)   Ahmad M, Riley TR, III. Can one predict when ultrasound will be useful with percutaneous liver biopsy? Am J Gastroenterol 2001; 96:547-9.

(84)   Dixon AK, Nunez DJ, Bradley JR, Seymour CA. Failure of percutaneous liver biopsy: anatomical variation. Lancet 1987; 2:437-9.

(85)   Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 1999; 45 Suppl 4:IV1-IV11.

(86)   Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30:1529-30.

(87)   Brouillette DE, Yoo YK, Chien MC, Rabinovitz M, Tarter RE, Van Thiel DH. Use of midazolam for percutaneous liver biopsy. Dig Dis Sci 1989; 34:1553-8.

(88)   Alexander JA, Smith BJ. Midazolam sedation for percutaneous liver biopsy. Dig Dis Sci 1993; 38:2209-11.

(89)   Castera L, Negre I, Samii K, Buffet C. Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: a randomized placebo-controlled trial. Am J Gastroenterol 2001; 96:1553-7.

(90)   Caldwell SH. Controlling pain in liver biopsy, or "we will probably need to repeat the biopsy in a year or two to assess the response". Am J Gastroenterol 2001; 96:1327-9.

(91)   Bateson MC, Hopwood D, Duguid HL, Bouchier IA. A comparative trial of liver biopsy needles. J Clin Pathol 1980; 33:131-3.

(92)   Vargas-Tank L, Martinez V, Jiron MI, Soto JR, Armas-Merino R. Tru-cut and Menghini needles: different yield in the histological diagnosis of liver disease. Liver 1985; 5:178-81.

(93)   Colombo M, Del Ninno E, de Franchis R, De Fazio C, Festorazzi S, Ronchi G et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988; 95:487-9.

(94)   Schiedermaier P, Neubrand M, Hansen S, Sauerbruch T. Variability of gallbladder emptying after oral stimulation. Scand J Gastroenterol 1997; 32:719-24.

(95)   Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 1980; 15:329-35.

(96)   Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 1983; 18:27-32.

(97)   Callard P, Sibony M. Comment traiter une biopsie hépatique? La biopsie hépatique en pathologie non tumorale du foie. Groupe METAVIR. Editions scientifiques et médicales Elsevier SAS, Paris., 2000: 2-12.

(98)   Hegarty JE, Williams R. Liver biopsy: techniques, clinical applications, and complications. Br Med J (Clin Res Ed) 1984; 288:1254-6.

(99)   Meng HC, Lin HC, Huang CC, Liao DM, Lee FY, Lee SD et al. Transjugular liver biopsy: comparison with percutaneous liver biopsy. J Gastroenterol Hepatol 1994; 9:457-61.

(100)   Baunsgaard P, Sanchez GC, Lundborg CJ. The variation of pathological changes in the liver evaluated by double biopsies. Acta Pathol Microbiol Scand [A] 1979; 87:51-7.

(101)   Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998; 28:323-31.

(102)   Demetris AJ, Belle SH, Hart J, Lewin K, Ludwig J, Snover DC et al. Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. The Liver Transplantation Database (LTD) Investigators. Hepatology 1991; 14:751-5.

(103)   Baggenstoss AH. Morphologic and etiologic diagnoses from hepatic biopsies without clinical data. Medicine (Baltimore) 1966; 45:435-43.

(104)   Scheuer P, Lefkowitch JH. General considerations. In: Scheuer P, Lefkowitch JH, editors. Liver biopsy interpretation. London: Hartcourt Publisher Limited, 2000: 1-11.

(105)   West AB, Chatila R. Differential diagnosis of bile duct injury and ductopenia. Semin Diagn Pathol 1998; 15:270-84.

(106)   Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1988; 7:193-9.

(107)   Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14:721-9.

(108)   Solis Herruzo JA. [Liver biopsy]. Rev Clin Esp 1989; 184:117-20.

(109)   Lee R. General principles. In: Lee RG, editor. Diagnostic liver pathology. St Louis: Mosby, 1994: 1-21.

(110)   Sherlock S, Dooley J. Needle biopsy of the liver. In: Sherlock S, Dooley J, editors. Diseases of the liver and biliary system. Oxford: Blackwell Scientific Publications, 1993: 33-43.

(111)   Thung SN, Shaffner F. Liver biopsy. In: Mac Sween RSP, Anthony PP, Scheuer P, Brunt AD, Portmann B, editors. Pathology of the liver. Edimburgh: 1994: 787-96.

(112)   Degott C. La biopsie hépatique. Act Med Int-Gastroentérol 1991; 8:135-7.

(113)   Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139:667-9.

(114)   Labayle D, Chaput JC, Albuisson F, Buffet C, Martin E, Etienne JP. Analyse histologique comparative des biopsies du lobe croit et du lobe gauche dans les lésions alcooliques du foie. Gastroenterol Clin Biol 1979; 3:235-40.

(115)   Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1:523-5.

(116)   Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WH. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1971; 16:1082-6.

(117)   Littlewood ER, Gilmore IT, Murray-Lyon IM, Stephens KR, Paradinas FJ. Comparison of the Trucut and Surecut liver biopsy needles. J Clin Pathol 1982; 35:761-3.

(118)   Thung SN, Gerber MA. Liver. In: Sternberg SS, editor. Histology for pathologists. Philadelphia: Lippincott-Raven, 1997: 575-91.

(119)   Sherlock S. Needle biopsy of the liver. J Clin Pathol 1962; 15:291-304.

(120)   Walters JR, Paton A. Procedures in practice. Liver biopsy. Br Med J 1980; 280:776-8.

(121)   Ishak KG, Schiff ER. Needle biopsy of the liver. In: Schiff L, Schiff ER, editors. Diseases of the liver. London: JB Lippincott Company, 1987: 399-441.

(122)   Millward-Sadler GH, Whorwell PJ. Liver biopsy: methods, diagnostic value and interpretation. In: Millward-Sadler GH, Wright R, Arthur MJP, editors. Wright's liver and biliary disease. Physiopathology, diagnosis and management. London: WB Saunders Company Ltd, 1992: 476-97.

(123)   Ishak KG, Markin RS. Liver. In: Damjanov I, Linder J, editors. Anderson's pathology. St Louis: Mosby, 1996: 1779-843.

(124)   Brown KE, Janney CG, et al. Liver biopsy: indications, technique, complications and interpretation. In: Bacon DBA, Di Bisceglie AM, editors. Liver diseases: diagnosis and management. New York: Churchill Livingstone, 2000: 47-75.

(125)   Galian A, Zafrani ES. La biopsie hépatique, son intérêt en pathologie. Ann Pathol 1982; 2:71-8.

(126)   Desmet VJ. What more can we ask from the pathologist? J Hepatol 1996; 25 Suppl 1:25-9.

(127)   Finn LS, Kinsley AS. Recommandations for handling of pediatric liver biopsy specimens. Sem Diagn Pathol 1998; 15:300-5.

(128)   Ruebner BH, Montgomery CK. A general approach to hepatic pathology. In: Ruebner BH, Montgomery CK, editors. Pathology of the liver and biliary tract. New York: John Wiley and Sons, 1982: 1-32.

(129)   O'Brien BD. Blood transfusion requirements after liver biopsy. Can J Gastroenterol 2000; 14:901-2.

(130)   Tobin MV, Gilmore IT. Plugged liver biopsy in patients with impaired coagulation. Dig Dis Sci 1989; 34:13-5.

(131)   Knauer CM. Percutaneous biopsy of the liver as a procedure for outpatients. Gastroenterology 1978; 74:101-2.

(132)   Westaby D, MacDougall BR, Williams R. Liver biopsy as a day-case procedure: selection and complications in 200 consecutive patients. Br Med J 1980; 281:1331-2.

(133)   Jacobs WH, Goldberg SB. Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 1989; 34:322-3.

(134)   Nouel O, Boutroux D, Ibn MN. Biopsie hépatique en ambulatoire: un procédé utile et sûr? Gastroenterol Clin Biol 1994; 18:1047-8.

(135)   Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology 1998; 27:1220-6.

(136)   Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998; 115:929-36.

(137)   Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol 1998; 28:439-46.

(138)   Guechot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol 1995; 22(2 Suppl):103-6.

(139)   Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-16.

(140)   Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-75.

(141)   Riley SA, Ellis WR, Irving HC, Lintott DJ, Axon AT, Losowsky MS. Percutaneous liver biopsy with plugging of needle track: a safe method for use in patients with impaired coagulation. Lancet 1984; 2:436.

(142)   Chuang VP, Alspaugh JP. Sheath needle for liver biopsy in high-risk patients. Radiology 1988; 166(1 Pt 1):261-2.

(143)   Zins M, Vilgrain V, Gayno S, Rolland Y, Arrive L, Denninger MH et al. US-guided percutaneous liver biopsy with plugging of the needle track: a prospective study in 72 high-risk patients. Radiology 1992; 184:841-3.

(144)   Smith TP, McDermott VG, Ayoub DM, Suhocki PV, Stackhouse DJ. Percutaneous transhepatic liver biopsy with tract embolization. Radiology 1996; 198:769-74.

(145)   Sawyerr AM, McCormick PA, Tennyson GS, Chin J, Dick R, Scheuer PJ et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol 1993; 17:81-5.

(146)   Velt PM, Choy OG, Shimkin PM, Link RJ. Transjugular liver biopsy in high-risk patients with hepatic disease. Radiology 1984; 153:91-3.

(147)   Azoulay D, Raccuia JS, Roche B, Reynes M, Bismuth H. The value of early transjugular liver biopsy after liver transplantation. Transplantation 1996; 61:406-9.

(148)   Papatheodoridis GV, Patch D, Watkinson A, Tibballs J, Burroughs AK. Transjugular liver biopsy in the 1990s: a 2-year audit. Aliment Pharmacol Ther 1999; 13:603-8.

(149)   Lebrec D, Buysschaert M, Degott C, Rueff B, Benhamou JP. La ponction-biopsie hépatique par voie transjugulaire. Nouv Presse Med 1976; 5:2135-7.

(150)   Lebrec D. La biopsie hépatique par voie transveineuse. Gastroenterol Clin Biol 1977; 1:741-3.

(151)   Brousse N, Solal-Celigny P, Degott C, Lebrec D. Biopsie hépatique par voie transveineuse dans les hémopathies avec troubles de la coagulation. Presse Med 1983; 12:2439-41.

(152)   Colapinto RF, Blendis LM. Liver biopsy through the transjugular approach. Modification of instruments. Radiology 1983; 148:306.

(153)   Gilmore IT, Bradley RD, Thompson RP. Improved method of transvenous liver biopsy. Br Med J 1978; 2:249.

(154)   Gorriz E, Reyes R, Lobrano MB, Pulido-Duque JM, San Roman JL, Lonjedo E et al. Transjugular liver biopsy: a review of 77 biopsies using a spring-propelled cutting needle (biopsy gun). Cardiovasc Intervent Radiol 1996; 19:442-5.

(155)   Little AF, Zajko AB, Orons PD. Transjugular liver biopsy: a prospective study in 43 patients with the Quick-Core biopsy needle. J Vasc Interv Radiol 1996; 7:127-31.

(156)   Kardache M, Soyer P, Boudiaf M, Cochand-Priollet B, Pelage JP, Rymer R. Transjugular liver biopsy with an automated device. Radiology 1997; 204:369-72.

(157)   Sada PN, Ramakrishna B, Thomas CP, Govil S, Koshi T, Chandy G. Transjugular liver biopsy: a comparison of aspiration and trucut techniques. Liver 1997; 17:257-9.

(158)   Gonzalez-Tutor A, Garcia-Valtuille R, Cerezal L, Bustamante M. Transjugular biopsy of the liver with an automated device. Acta Radiol 1998; 39:686-9.

(159)   Choh J, Dolmatch B, Safadi R, Long P, Geisinger M, Lammert G et al. Transjugular core liver biopsy with a 19-gauge spring-loaded cutting needle. Cardiovasc Intervent Radiol 1998; 21:88-90.

(160)   De Hoyos A, Loredo ML, Martinez-Rios MA, Gil MR, Kuri J, Cardenas M. Transjugular liver biopsy in 52 patients with an automated Trucut-type needle. Dig Dis Sci 1999; 44:177-80.

(161)   Trejo R, Alvarez W, Garcia-Pagan JC, Feu F, Escorsell A, Bruguera M et al. [The applicability and diagnostic effectiveness of transjugular liver biopsy]. Med Clin (Barc ) 1996; 107:521-3.

(162)   Gamble P, Colapinto RF, Stronell RD, Colman JC, Blendis L. Transjugular liver biopsy: a review of 461 biopsies. Radiology 1985; 157:589-93.

(163)   Brenard R, Horsmans Y, Rahier J, Druez P, Descamps C, Geubel A. Transjugular liver biopsy. An experience based on 500 procedures. Acta Gastroenterol Belg 1997; 60:138-41.

(164)   Braillon A, Revert R, Remond A, Auderbert M, Capron JP. Transcatheter embolization of liver capsule perforation during transvenous liver biopsy. Gastrointest Radiol 1986; 11:277-9.

(165)   Corr P, Beningfield SJ, Davey N. Transjugular liver biopsy: a review of 200 biopsies. Clin Radiol 1992; 45:238-9.

(166)   Bret PM, Labadie M, Bretagnolle M, Paliard P, Fond A, Valette PJ. Hepatocellular carcinoma: diagnosis by percutaneous fine needle biopsy. Gastrointest Radiol 1988; 13:253-5.

(167)   Renard P, Minault S, Aucouturier JP, Pluot M, Faroux MJ, Zeitoun P. Ponctions échoguidées des masses hépatiques: la cytologie n'est-elle pas suffisante? Gastroenterol Clin Biol 1992; 16:473-4.

(168)   Glenthoj A, Sehested M, Torp-Pedersen S. Diagnostic reliability of histological and cytological fine needle biopsies from focal liver lesions. Histopathology 1989; 15:375-83.

(169)   Fornari F, Civardi G, Cavanna L, Rossi S, Buscarini E, Di Stasi M et al. Ultrasonically guided fine-needle aspiration biopsy: a highly diagnostic procedure for hepatic tumors. Am J Gastroenterol 1990; 85:1009-13.

(170)   Farnum JB, Patel PH, Thomas E. The value of Chiba fine-needle aspiration biopsy in the diagnosis of hepatic malignancy: a comparison with Menghini needle biopsy. J Clin Gastroenterol 1989; 11:101-9.

(171)   Fornari F, Filice C, Rapaccini GL, Caturelli E, Cavanna L, Civardi G et al. Small (< or = 3 cm) hepatic lesions. Results of sonographically guided fine-needle biopsy in 385 patients. Dig Dis Sci 1994; 39:2267-75.

(172)   Borzio M, Borzio F, Macchi R, Croce AM, Bruno S, Ferrari A et al. The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis. J Hepatol 1994; 20:117-21.

(173)   de S, I, Castellano L, Calandra M, Vecchio-Blanco C. Ultrasound-guided biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. J Hepatol 1997; 26:1155-6.

(174)   Labadie H, Seror O, Beaugrand M. Faut-il biopsier les petits nodules du foie? Gastroenterol Clin Biol 1999; 23:540-3.

(175)   Sbolli G, Fornari F, Civardi G, Di Stasi M, Cavanna L, Buscarini E et al. Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma. Gut 1990; 31:1303-5.

(176)   Longchampt E, Patriarche C, Fabre M. Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases. Acta Cytol 2000; 44:515-23.

(177)   Lee MJ, Mueller PR, Dawson SL, McLaughlin DT, Kinney T, Hahn PF et al. Measurement of tissue carcinoembryonic antigen levels from fine-needle biopsy specimens: technique and clinical usefulness. Radiology 1992; 184:717-20.

(178)   Gottschalk-Sabag S, Ron N, Glick T. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates. Acta Cytol 1998; 42:691-6.

(179)   Takenaka A, Kaji I, Kasugai H, Sasaki Y, Ishiguro S, Wada A et al. Usefulness of diagnostic criteria for aspiration cytology of hepatocellular carcinoma. Acta Cytol 1999; 43:610-6.

(180)   de Boer WB, Segal A, Frost FA, Sterrett GF. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies? Cancer 2000; 90:273-8.

(181)   Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, Chen DS. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. J Hepatol 1996; 25:334-8.

(182)   Bell DA, Carr CP, Szyfelbein WM. Fine needle aspiration cytology of focal liver lesions. Results obtained with examination of both cytologic and histologic preparations. Acta Cytol 1986; 30:397-402.

(183)   Caturelli E, Bisceglia M, Fusilli S, Squillante MM, Castelvetere M, Siena DA. Cytological vs microhistological diagnosis of hepatocellular carcinoma: comparative accuracies in the same fine-needle biopsy specimen. Dig Dis Sci 1996; 41:2326-31.

(184)   Herszenyi L, Farinati F, Cecchetto A, Marafin C, de Maria N, Cardin R et al. Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology. Ital J Gastroenterol 1995; 27:473-8.

(185)   Bedenne L, Mottot C, Courtois B, Meny B, Cauvin JM, Hillon P et al. L'aiguille Tru-Cut est-elle plus efficace que l'aiguille fine dans le diagnostic des lésions hépatiques? Gastroenterol Clin Biol 1990; 14:62-6.

(186)   Seitz JF, Giovannini M, Monges G, Rosello R, Hassoun J, Mazel C et al. Etude comparative de la cytologie à l'aiguille fine et de la biopsie à l'aiguille de fort calibre sous contrôle échographique dans le diagnostic des tumeurs abdominales. Gastroenterol Clin Biol 1990; 14:529-33.

(187)   Ch YS, Metreweli C, Lau WY, Leung WT, Liew CT, Leung NW. Safety of percutaneous biopsy of hepatocellular carcinoma with an 18 gauge automated needle. Clin Radiol 1997; 52:907-11.

(188)   Andersson T, Eriksson B, Lindgren PG, Wilander E, Oberg K. Percutaneous ultrasonography-guided cutting biopsy from liver metastases of endocrine gastrointestinal tumors. Ann Surg 1987; 206:728-32.

(189)   Charboneau JW, Reading CC, Welch TJ. CT and sonographically guided needle biopsy: current techniques and new innovations. AJR Am J Roentgenol 1990; 154:1-10.

(190)   Reix N, Joly JP, Sevestre H, Capron JP. Ponction des tumeurs solides du foie à l'aiguille de gros calibre guidée par l'échographie. Etude de 70 ponctions. Gastroenterol Clin Biol 1988; 12:508-11.

(191)   Drinkovic I, Brkljacic B. Two cases of lethal complications following ultrasound-guided percutaneous fine-needle biopsy of the liver. Cardiovasc Intervent Radiol 1996; 19:360-3.

(192)   Caldironi MW, Mazzucco M, Aldinio MT, Paccagnella D, Zani S, Pontini F et al. [Echo-guided fine-needle biopsy for the diagnosis of hepatic angioma. A report on 114 cases]. Minerva Chir 1998; 53:505-9.

(193)   Solbiati L, Livraghi T, De Pra L, Ierace T, Masciadri N, Ravetto C. Fine-needle biopsy of hepatic hemangioma with sonographic guidance. AJR Am J Roentgenol 1985; 144:471-4.

(194)   Heilo A, Stenwig AE. Liver hemangioma: US-guided 18-gauge core-needle biopsy. Radiology 1997; 204:719-22.

(195)   Taavitsainen M, Airaksinen T, Kreula J, Paivansalo M. Fine-needle aspiration biopsy of liver hemangioma. Acta Radiol 1990; 31:69-71.

(196)   Cronan JJ, Esparza AR, Dorfman GS, Ridlen MS, Paolella LP. Cavernous hemangioma of the liver: role of percutaneous biopsy. Radiology 1988; 166:135-8.

(197)   Menu Y. Biopsie guidée des tumeurs du foie: peut-on espérer un consensus? Gastroenterol Clin Biol 1988; 12:505-7.

(198)   Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22:1674-81.

(199)   Souto E, Gores GJ. When should a liver mass suspected of being a hepatocellular carcinoma be biopsied? Liver Transpl 2000; 6:73-5.

(200)   Bissonnette RT, Gibney RG, Berry BR, Buckley AR. Fatal carcinoid crisis after percutaneous fine-needle biopsy of hepatic metastasis: case report and literature review. Radiology 1990; 174:751-2.

(201)   Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology 1991; 178:253-8.

(202)   Nolsoe C, Nielsen L, Torp-Pedersen S, Holm HH. Major complications and deaths due to interventional ultrasonography: a review of 8000 cases. J Clin Ultrasound 1990; 18:179-84.

(203)   Chapoutot C, Perney P, Fabre D, Taourel P, Bruel JM, Larrey D et al. Essaimages tumoraux sur le trajet de ponctions échoguidées de carcinomes hépatocellulaires.Etude de 150 malades. Gastroenterol Clin Biol 1999; 23:552-6.

(204)   Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000; 25:246-50.

(205)   Takamori R, Wong LL, Dang C, Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000; 6:67-72.

(206)   Dumortier J, Lombard-Bohas C, Valette PJ, Boillot O, Scoazec JY, Berger F et al. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 2000; 47:301.

(207)   Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001; 35:254-8.

(208)   Azoulay D, Johann M, Raccuia JS, Castaing D, Bismuth H. "Protected" double needle biopsy technique for hepatic tumors. J Am Coll Surg 1996; 183:160-3.

(209)   Louha M, Nicolet J, Zylberberg H, Sabile A, Vons C, Vona G et al. Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 1999; 29:879-82.

(210)   Stewart ET. Is a single negative core biopsy, clearly obtained from a suspicious lesion in the cirrhotic liver, sufficient to exclude the diagnosis of hepatocellular carcinoma as the cause of the lesion? AJR Am J Roentgenol 1994; 163:1525.

(211)   Bru C, Maroto A, Bruix J, Faus R, Bianchi L, Calvet X et al. Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma. Dig Dis Sci 1989; 34:1765-9.

(212)   Yu SC, Lau WY, Leung WT, Liew CT, Leung NW, Metreweli C. Percutaneous biopsy of small hepatic lesions using an 18 gauge automated needle. Br J Radiol 1998; 71:621-4.

(213)   Taourel P, Benkirane K, Barneon G, Larrey D, Blanc F, Pradel J et al. Facteurs d'échec de la ponction guidée des masses hépatiques. Gastroenterol Clin Biol 1993; 17:892-6.

(214)   Dumas O, Roget L, Coppere H, David A, Richard P, Barthelemy C et al. Etude comparée des données de la cytoponction à l'aiguille fine et des aspects échographiques des formations tumorales hépatiques en fonction des circonstances de découverte.A propos de 206 patients. Gastroenterol Clin Biol 1990; 14:67-73.

(215)   Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30:889-93.

(216)   Vilgrain V, Flejou JF, Arrive L, Belghiti J, Najmark D, Menu Y et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 1992; 184:699-703.

(217)   Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35:421-30.

(218)   Furuya KN, Burrows PE, Phillips MJ, Roberts EA. Transjugular liver biopsy in children. Hepatology 1992; 15:1036-42.

(219)   Hoffer FA. Liver biopsy methods for pediatric oncology patients. Pediatr Radiol 2000; 30:481-8.

(220)   Scheimann AO, Barrios JM, Al Tawil YS, Gray KM, Gilger MA. Percutaneous liver biopsy in children: impact of ultrasonography and spring-loaded biopsy needles. J Pediatr Gastroenterol Nutr 2000; 31:536-9.

(221)   Gonzalez-Vallina R, Alonso EM, Rand E, Black DD, Whitington PF. Outpatient percutaneous liver biopsy in children. J Pediatr Gastroenterol Nutr 1993; 17:370-5.

(222)   Cohen MB, Kader HH, Lambers D, Heubi JE. Complications of percutaneous liver biopsy in children. Gastroenterology 1992; 102:629-32.